CAS 4741-41-7

Dexoxadrol

Description:

Dexoxadrol, with the CAS number 4741-41-7, is a synthetic compound that belongs to the class of drugs known as adrenergic agents. It is primarily characterized by its ability to act as a stimulant, influencing the central nervous system and potentially affecting cardiovascular functions. Dexoxadrol is known for its selective action on certain adrenergic receptors, which can lead to increased heart rate and blood pressure. The compound is often studied for its pharmacological properties, including its potential applications in treating conditions related to hypotension or other cardiovascular issues. In terms of physical properties, Dexoxadrol is typically a crystalline solid, and its solubility can vary depending on the solvent used. As with many synthetic compounds, safety and toxicity profiles are essential considerations, and research continues to explore its therapeutic potential and side effects. Overall, Dexoxadrol represents a significant interest in pharmacology, particularly in the context of adrenergic modulation.

Formula: C₂₀H₂₃NO₂

InChI: InChI=1S/C20H23NO2/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2/t18-,19+/m0/s1

InChI key: InChIKey=HGKAMARNFGKMLC-RBUKOAKNSA-N

SMILES: C1(O[C@](CO1)([C@@]2(CCCCN2)[H])[H])(C3=CC=CC=C3)C4=CC=CC=C4

Synonyms:

• Piperidine, 2-(2,2-diphenyl-1,3-dioxolan-4-yl)-
• Piperidine, 2-[(4S)-2,2-diphenyl-1,3-dioxolan-4-yl]-, (2S)-
• (2S)-2-[(4S)-2,2-Diphenyl-1,3-dioxolan-4-yl]piperidine
• Piperidine, 2-(2,2-diphenyl-1,3-dioxolan-4-yl)-, (R*,R*)-(+)-
• Piperidine, 2-(2,2-diphenyl-1,3-dioxolan-4-yl)-, [S-(R*,R*)]-

Dexoxadrol

CAS: 4741-41-7

Dexoxadrol is a phencyclidine derivative that has been shown to have locomotor activity and receptor binding properties. Dexoxadrol binds to the phencyclidine site on the NMDA receptor, which is a ligand-gated ion channel, and inhibits the flow of ions through this channel. This leads to an increase in extracellular sodium and calcium. Dexoxadrol also binds to the dopamine D1 receptor and the GABA A receptor, making it an antagonist at these sites. Dexoxadrol has been shown to have low potency in experimental models and may be used as a research tool for studying dopamine receptors, cerebellar purkinje neurons, or fatty acid metabolism.

Formula: C₂₀H₂₃NO₂

Purity: Min. 95%

Molecular weight: 309.4 g/mol

Ref: 3D-EAA74141